Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan

OBJECTIVE: Ascites becomes refractory to diuretics in cirrhotic patients, who then require repeated large-volume paracentesis or cell-free and concentrated ascites reinfusion therapy (CART). The objective of this study was to confirm the safety and efficacy of CART, evaluate the actual situations wi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Intern Med
Päätekijät: Iwasa, Motoh, Ishihara, Tomoaki, Kato, Michio, Isoai, Ayako, Kobayashi, Ryosuke, Torii, Naoko, Soneda, Noriko, Takei, Yoshiyuki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Japanese Society of Internal Medicine 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875447/
https://ncbi.nlm.nih.gov/pubmed/31292400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.3091-19
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia